Hybrigenics SA
EPA:ALHYG.PA
0.0103 (EUR) • At close June 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.384 | 0.002 | 0.147 | 0.151 | 0.235 | 0.077 | 1.88 | 3.606 | 4.635 | 5.549 | 5.622 | 4.577 | 2.255 | 3.735 | 4.169 |
| Cost of Revenue
| 0.53 | 0.387 | 0.007 | 0 | 0.001 | 0.032 | 4.463 | 1.016 | 4.044 | 4.431 | 3.633 | 4.138 | 3.403 | 0.698 | 0.753 |
| Gross Profit
| -0.146 | -0.385 | 0.14 | 0.151 | 0.234 | 0.045 | -2.583 | 2.59 | 0.591 | 1.118 | 1.989 | 0.439 | -1.148 | 3.037 | 3.416 |
| Gross Profit Ratio
| -0.381 | -246.858 | 0.952 | 0.999 | 0.995 | 0.588 | -1.374 | 0.718 | 0.128 | 0.201 | 0.354 | 0.096 | -0.509 | 0.813 | 0.819 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0.007 | 3.367 | 2.549 | 1.548 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0.236 | 0.802 | 5.74 | 2 | 2.064 | 2.204 | 0 | 3.529 | 4.018 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0.586 | -0.002 | -0.008 | 0 | 0 | 0 | 0 | 4.115 | 4.329 |
| SG&A
| 0 | 0.202 | 0.265 | 0.236 | 0.802 | 5.74 | 2.586 | 2.062 | 2.204 | 4.381 | 3.529 | 4.018 | 0 | 4.115 | 4.329 |
| Other Expenses
| 0 | 0.592 | 0.123 | 0.081 | 0.792 | 1.943 | 2.202 | 1.481 | 0.587 | 4.54 | 0.684 | 0.009 | -0.013 | 3.786 | 4.02 |
| Operating Expenses
| 13.485 | 0.592 | 0.123 | 0.317 | 1.594 | 7.683 | 4.795 | 6.91 | 5.596 | 4.54 | 4.213 | 4.135 | 2.084 | 7.901 | 8.349 |
| Operating Income
| -0.753 | -0.59 | -0.123 | -0.317 | -1.361 | -7.638 | -7.377 | -4.32 | -4.414 | -3.624 | -2.408 | -3.721 | -3.232 | -4.864 | -4.933 |
| Operating Income Ratio
| -1.962 | -378.298 | -0.838 | -2.105 | -5.791 | -99.542 | -3.924 | -1.198 | -0.952 | -0.653 | -0.428 | -0.813 | -1.433 | -1.302 | -1.183 |
| Total Other Income Expenses Net
| -12.757 | 0.018 | 0.42 | 0.036 | -0.171 | -0.189 | 0.082 | 0.031 | 0.083 | 0.029 | -0.02 | -0.012 | 0.178 | -0.136 | 0.018 |
| Income Before Tax
| -13.51 | -0.572 | 0.297 | -0.281 | -1.532 | -7.826 | -7.295 | -4.289 | -4.331 | -3.595 | -2.428 | -3.733 | -3.054 | -5 | -4.915 |
| Income Before Tax Ratio
| -35.202 | -366.946 | 2.016 | -1.867 | -6.52 | -101.999 | -3.88 | -1.189 | -0.934 | -0.648 | -0.432 | -0.816 | -1.354 | -1.339 | -1.179 |
| Income Tax Expense
| -7.288 | -0.009 | -0 | 0.048 | -0.609 | -0.303 | 0.662 | 0.968 | 0.014 | -0.573 | -0.601 | -0.322 | -0.762 | -0.442 | -0.719 |
| Net Income
| -18.847 | -0.564 | 0.297 | -0.329 | -0.923 | -7.528 | -7.957 | -5.257 | -4.375 | -2.92 | -1.788 | -2.454 | -2.292 | -4.558 | -4.196 |
| Net Income Ratio
| -49.105 | -361.263 | 2.017 | -2.185 | -3.929 | -98.114 | -4.232 | -1.458 | -0.944 | -0.526 | -0.318 | -0.536 | -1.016 | -1.22 | -1.006 |
| EPS
| -0.049 | -0.002 | 0.001 | -0.001 | -0.004 | -0.19 | -0.2 | -0.15 | -0.12 | -0.11 | -0.076 | -0.13 | -0.16 | -0.35 | -0.35 |
| EPS Diluted
| -0.049 | -0.002 | 0.001 | -0.001 | -0.004 | -0.19 | -0.2 | -0.15 | -0.12 | -0.11 | -0.076 | -0.13 | -0.16 | -0.35 | -0.35 |
| EBITDA
| -0.451 | -0.508 | -0.062 | -0.269 | -1.269 | -7.394 | -7.145 | -3.006 | -3.614 | -3.026 | -1.688 | -3.181 | -2.661 | -3.783 | -3.988 |
| EBITDA Ratio
| -1.174 | -325.479 | -0.422 | -1.783 | -5.4 | -96.369 | -3.801 | -0.834 | -0.78 | -0.545 | -0.3 | -0.695 | -1.18 | -1.013 | -0.957 |